MedTrace Logo

Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers

NCT05077007 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2022-02-22

No results posted yet for this study

Summary

The study evaluate the damage effect of ESWL and PCNL on kidney tissue by measuring non-coding lnc-RNA profile in urine before and after ESWL and PCNL procedures

Conditions

  • Acute Kidney Injury
  • Renal Calculi
  • Percutaneous Nephrolithotomy
  • Extracorporeal Shockwave Lithotripsy

Interventions

PROCEDURE

Percutaneous nephrolithotomy

Endoscopic stone Extraction from the kidney by making a puncture and dilate a tract direct into the kidney through muscle wall and renal parenchyma

PROCEDURE

Extracorporeal Shock Wave Lithotripsy

Using Shock waves from outside the body targeted at a kidney stone causing the stone to fragment. The stones are broken into tiny pieces.

Sponsors & Collaborators

  • Science,Technology & Innovation Funding Authority

    collaborator UNKNOWN

  • Ain Shams University

    lead OTHER

Principal Investigators

  • waleed Mousa · Urology Department, Ain Shams University, Abassia, Cairo

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-08-22
Completion
2022-11-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077007 on ClinicalTrials.gov